NeuroSigma Announces Promotion of Dr. Colin Kealey to President
11 janv. 2022 11h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone
22 sept. 2020 07h00 HE
|
Q BioMed Inc.
AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
Q BioMed, Inc. CEO Discusses Recently Announced Global Distribution Partnership with Caligor Coghlan Pharma Services in Audio Interview with SmallCapVoice.com
09 juil. 2020 08h00 HE
|
Q BioMed Inc.
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
OmniPathology Receives FDA Emergency Use Authorization for New Omni-COVID-19 Molecular Test
22 juin 2020 08h45 HE
|
OmniPathology
PASADENA, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- OmniPathology today announced that it has received an FDA Emergency Use Authorization EUA letter for its Omni-COVID-19 Assay polymerase chain...
Denis Corin, CEO, of Q BioMed Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
30 avr. 2020 08h00 HE
|
Q BioMed Inc.
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the "Company"), a commercial stage biotechnology company, announced today that a new audio...
US FDA clears behold.ai’s AI algorithm for radiology triage
12 mars 2020 08h00 HE
|
Behold.ai Technologies Limited
US FDA clears behold.ai’s AI algorithm for radiology triage LONDON March 12, 2020 – The US Food and Drug Administration (FDA) has cleared the use of behold.ai’s red dot® algorithm for ‘instant...
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
01 juil. 2019 08h57 HE
|
BioElectronics Corporation
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
12 juil. 2016 09h30 HE
|
Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Medical Device Helps Audiologists Improve Hearing Aid Performance, Increase Patient Satisfaction
18 sept. 2012 10h53 HE
|
Now Hear This
RALEIGH, N.C., Sept. 18, 2012 (GLOBE NEWSWIRE) -- An audiologist at the practice, Now Hear This is the first in the US to use a device that greatly improves the performance of hearing aids, an...
TAGI Pharma Announces Exclusive Marketing Rights Agreement for Codeine Sulfate Oral Solution CII, 30MG/5ML
10 avr. 2012 08h30 HE
|
TAGI Pharma, Inc.
SOUTH BELOIT, Ill., April 10, 2012 (GLOBE NEWSWIRE) -- TAGI Pharma, Inc., a subsidiary of Precision Dose, Inc., announced today the signing of an exclusive marketing rights agreement to market and...